The novel small molecule Myo4 normalises glycemic control, reduces weight/fat mass and prevents semaglutide-induced muscle remodelling in the murine diet-induced obesity model

Back to All Posts
  • Publication

The 32nd European Congress on Obesity – Obesity Facts (2025) 18 (Suppl. 1) Abstract AD11.06. Holder J et al ‘The novel small molecule Myo4 normalises glycemic control, reduces weight/fat mass and prevents semaglutide-induced muscle remodelling in the murine diet-induced obesity model’

Read publication: https://doi.org/10.1159/000545547